TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $89
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $68 to $89.
TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $68 to $89.